Back to search
FDAFDA · Food and drugs·Recall number D-1153-2018

Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

Published September 5, 2018 · Recall initiated: August 2, 2018

Summary

FDA records drug Class II recall D-1153-2018, published September 5, 2018 and initiated August 2, 2018. Recalling firm: Pharmcore Inc.; Status: Terminated; Reported quantity: 6 vials; Lot: Lot: IPA3-17 Exp. 07/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmcore Inc.
Distributor
Nationwide
Lot
Lot: IPA3-17 Exp. 07/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009 recalled?

Yes. FDA published recall D-1153-2018 on September 5, 2018. Reported hazard: Lack of assurance of sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter